Clinical Trial Update: Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer [NA]

View source ↗

Summary

The clinical trial using PET tracers carbon-11 acetate and fluorine-18 sodium fluoride to assess treatment response in hormone-resistant metastatic prostate can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Carbon-11 Acetate (11C-acetate)
• Fluorine-18 Sodium Fluoride (18F-sodium fluoride)

Snippet

Sponsor: University of Washington | Conditions: Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer | NA | Status: WITHDRAWN